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Analysis of degree and rate of healing was performed based
on initial wound size.
Results:The study included142LEBand148EVpatients
with similar age (EV 70, LEB 71), diabetes mellitus (EV 58%,
LEB 41%), and chronic renal failure (EV 24%, LEB 21%). EV
procedures (balloon angioplasty n 20, stent deployment n
82, atherectomy n  30, and cryoplasty n  10) treated SFA
(30%), popliteal (19%), and tibial (51%) lesions with 2.8 lesions
treated per patient. LEB included 98 vein grafts and 44 using
PTFE with a distal vein patch. Target arteries included BK pop-
liteal (n 14), anterior tibial (n 46), posterior tibial (n 41),
and peroneal (n 41). Therewas no difference in average initial
wound size (EV14.1mm,LEB14.6mm)with complete healing
in 76% after LEB and 41% after EV (p 0.013). This difference
was significant in larger wounds (Group C) with complete heal-
ing in 70%LEB and 27%EV (p 0.02). A shortermedian time
to healing was noted after bypass; LEB 98 days, EV 132 days
(p 0.048). There were 40 amputations; EV 30 (20% total, 8%
major), and LEB 10 (7% total, 2.8%major).
Conclusions: This comparison of wound healing after
bypass or endovascular revascularization demonstrates
more complete healing and a faster rate of healing after
open bypass for larger wounds ( 2 cm). Initial wound size
should be a consideration in choosing the method of
revascularization for ischemic wounds.
Healing based on initial wound size
Group LEB EV
A (0-5 mm) 81.1% 94 days 53.8% 105 days
B (5.1 – 20 mm) 76.2% 102 days 41.7% 128 days
C ( 20 mm) * 70.2% 115 days 27.1% 164 days
*p  0.01
Author Disclosures: C. E. Attinger: Nothing to disclose;
J. Babrowicz: Nothing to disclose; D. Deaton: Nothing
to disclose; J. Laredo: Nothing to disclose; R. F. Neville:
WL Gore, Honorarium; J. Steinberg: Nothing to disclose.
VS 3.
Video Presentation
Popliteal to Dorsalis Pedis Translocated Vein Graft
Frank W. LoGerfo1, Frank B. Pomposelli1, Allen Hamdan1,
Bernadette Aulivola2. 1Beth Israel Deaconess Medical Center,
Boston,MA; 2Loyola UniversityMedical center, Chicago, IL
Background: Autogenous vein bypass grafts to the dor-
salis pedis artery are an essential surgical skill in the care of
patients with foot ulcers associated with Diabetes Mellitus.
Technical Description: This is a video showing the key
steps in the performance of a popliteal to dorsalis pedis translo-
cated vein graft demonstrating angioscopically verified valve lysis.
Author Disclosures: B. Aulivola: Nothing to disclose; A.
Hamdan: Nothing to disclose; F. W. LoGerfo: Nothing
to disclose; F. B. Pomposelli: Nothing to disclose.SS17.
Vacuum-Assisted Closure (VAC) Therapy for the Treat-
ment of Deep (Szilagyi Grade III-Infection) in the Groin
Ramesh Tripathi1, Kiriakos Ktenidis2. 1Vascular & Endo-
vascular Surgery, Indraprastha Apollo Hospital, New
Delhi, Hungary; 2Aristotle University, Thessaloniki, Greece
Objectives: To evaluate the benefit of vacuum-assisted
closure (VAC) therapy for the treatment of deep alloplastic
graft infections (Szilagyi Grade III-Infection) in the groin.
Methods: From 2000 to 2009, 72 deep inguinal infec-
tions involving native as well as synthetic graft or patch
material. There were 29 early graft infections ( 30 days
after implantation) and 43 late infections. 55 cases involved
non-native grafts/patches (26 PTFE grafts, 24 Dacron
grafts, 5 Vascuguard Bovine Pericardial patches). All pa-
tients were treated with multiple wound debridements,
graft salvage, sartorius myoplasty, IV antibiotics and VAC
dressings till thru-surface healing was achieved. Exclusion
criteria were an alloplastic graft infection with proximal
expansion above the inguinal ligament, blood culture pos-
itive septicaemia or septic anastomotic herald or overt
bleeding.
Results: At 9 months, overall, graft/patch salvage was
achieved in 70/72 (97.2%) patients. In the non-native
group, vein or synthetic graft preservation without revision
was achieved in 48/55 (82.27%) patients. The mean dura-
tion of VAC treatment was 16  7.7 days, postoperative
mean hospital stay was 25.3 8.5 days. In 23 (31.9%) cases
a secondary closure of the wound could be achieved. In 49
cases wound healing was achieved by meshed split skin
grafting. Mean wound healing time for all wounds was
24.3 12.5 days. Mean postoperative follow-up was 4.3
3.5 years with no procedure-related mortality. Specific
complications during VAC-therapy were wound fluid re-
tention in 2 cases and an increased need for analgesics in 12
patients.
Conclusions: Even in the presence of synthetic vascu-
lar graft material, negative pressure therapy can greatly
simplify challenging wound-healing problems. Our long-
term experience demonstrates the safety and effectiveness
of VAC-therapy for the treatment of deep graft infections.
Author Disclosures: K. Ktenidis: Nothing to disclose; R.
Tripathi: Nothing to disclose.
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Low Rehospitalization Rate for Vascular Surgery Pa-
tients at a Single University Hospital
Benjamin M. Jackson1, Lynne Doctor2, Derek Nathan3,
Grace J. Wang1, Edward Y. Woo1, Ronald M. Fairman1.
1Hospital of the Univeristy of Pennsylvania - Division of
Vascular Surgery, Philadelphia, PA; 2University of Pennsyl-
vania School ofMedicine, Philadelphia, PA; 3General Surgery,
Hospital of the University of Pennsylvania, Philadelphia, PA
Objectives: Reducing rehospitalization rates has been
proposed to improve care, reduce costs, and as a pay-for-
performance criterion. Recent review of Medicare claims
